Harpoon Therapeutic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harpoon therapeutic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harpoon Therapeutic Today - Breaking & Trending Today

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies

Patented AI Platform Identifies Promising Early-Stage BioPharma Assets and Companies
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Corporation On , Clinical Development Decisions With Validated Pos Assessments , Kinnate Biopharma Inc , Glimpse Behind , Sharpe Ratio , Harpoon Therapeutic , Antibody Drug Conjugate , Better Investment , Clinical Development Decisions With Validated Pos ,

While private equity firms own 20% of Harpoon Therapeutics, Inc. (NASDAQ:HARP), retail investors are its largest shareholders with 36% ownership

Key Insights Significant control over Harpoon Therapeutics by retail investors implies that the general public has more. ....

Harpoon Therapeutics Inc , Merck Co Inc , Public Company Ownership , Harpoon Therapeutic , Harpoon Therapeutics , Retail Investors , Private Equity Firms ,

Leerink Partnrs Lowers Harpoon Therapeutics (NASDAQ:HARP) to Market Perform

Leerink Partnrs lowered shares of Harpoon Therapeutics (NASDAQ:HARP – Free Report) from an outperform rating to a market perform rating in a research report released on Monday, PriceTargets.com reports. Leerink Partnrs also issued estimates for Harpoon Therapeutics’ FY2025 earnings at ($2.09) EPS. Several other brokerages have also commented on HARP. Oppenheimer started coverage on Harpoon […] ....

United States , Leerink Partnrs , Renaissance Technologies , Capital Management , Goldman Sachs Group Inc , Canaccord Genuity Group , Dimensional Fund Advisors , Harpoon Therapeutics Inc , Sequoia Financial Advisors , Harpoon Therapeutics , Free Report , Harpoon Therapeutic , Genuity Group , Moderate Buy , Get Free Report , Fund Advisors , Sachs Group , Harpoon Therapeutics Daily , Nasdaq Harp ,

Equities Analysts Issue Forecasts for Harpoon Therapeutics, Inc.'s FY2028 Earnings (NASDAQ:HARP)

Harpoon Therapeutics, Inc. (NASDAQ:HARP – Free Report) – Equities research analysts at HC Wainwright issued their FY2028 earnings estimates for shares of Harpoon Therapeutics in a research report issued on Monday, January 8th. HC Wainwright analyst S. Ramakanth forecasts that the company will earn $1.58 per share for the year. HC Wainwright currently has a […] ....

United States , Leerink Partnrs , Canaccord Genuity Group , Delphia United States Inc , Harpoon Therapeutics Inc , Renaissance Technologies , Sequoia Financial Advisors , Harpoon Therapeutics , Free Report , Harpoon Therapeutic , Get Free Report , Genuity Group , Financial Advisors , Sigma Investments , Harpoon Therapeutics Daily , Nasdaq Harp , Earnings Estimates , Hc Wainwright ,

Harpoon Therapeutics, Inc. (NASDAQ:HARP) to Post FY2025 Earnings of ($2.09) Per Share, Leerink Partnrs Forecasts

Harpoon Therapeutics, Inc. (NASDAQ:HARP – Free Report) – Research analysts at Leerink Partnrs issued their FY2025 EPS estimates for Harpoon Therapeutics in a research note issued to investors on Monday, January 8th. Leerink Partnrs analyst J. Chang expects that the company will post earnings of ($2.09) per share for the year. Leerink Partnrs currently has […] ....

United States , Leerink Partnrs , Susquehanna International Group , Harpoon Therapeutics Inc , Sequoia Financial Advisors , Prudential Financial Inc , Harpoon Therapeutics Company Profile , Canaccord Genuity Group , Harpoon Therapeutics , Free Report , Harpoon Therapeutic , Get Free Report , Sigma Investments , International Group , Harpoon Therapeutics Daily , Nasdaq Harp , Earnings Estimates ,